CJC-1295 / Ipamorelin Blend
$78.00
CJC-1295 / Ipamorelin Blend — dual-receptor GH-axis activation in one vial. Published research shows 2-3x synergistic GH output vs. single-agent protocols. 99%+ purity, HPLC verified.
Description
CJC-1295 / Ipamorelin Blend: Dual-Receptor GH Synergy in a Single Vial
Here’s a number that changed GH-axis research: 2-3x. That’s the amplification factor when you co-activate GHRH-R and GHS-R1a simultaneously versus hitting either receptor alone. Bowers documented it in 1998 (Journal of Pediatric Endocrinology). Veldhuis confirmed the underlying mechanism in 2012 (Endocrine Reviews). Two distinct receptor pathways converge on the same somatotroph cell, and the intracellular signaling cascades multiply rather than add.
This blend puts both activators in one vial. No separate reconstitutions. No timing calculations. One peptide solution, two receptor targets, synergistic output.
Why Two Receptors Beat One — The Science of GH Synergy
CJC-1295 is a GHRH analog. It binds GHRH-R on pituitary somatotrophs and activates the cAMP/PKA signaling cascade. This pathway primes GH vesicles for release and upregulates GH gene transcription.
Ipamorelin is a ghrelin mimetic. It binds GHS-R1a on those same somatotrophs and activates the PLC/IP3/calcium pathway. This triggers direct vesicle exocytosis — the physical release of stored GH granules.
One pathway loads the gun. The other pulls the trigger. Together, you get both increased GH production AND increased GH release. The math isn’t 1+1=2. Published data consistently shows 1+1=3 or higher.
Veldhuis et al. (2012) mapped this at the molecular level: cAMP-dependent priming sensitizes the calcium-dependent release machinery. The somatotroph becomes hyper-responsive to the GHS signal when GHRH-R is already activated. That’s genuine pharmacological synergy, not marketing language.
The Ipamorelin Advantage in This Pairing
Why Ipamorelin specifically? Selectivity. GHRP-6 would also activate GHS-R1a, but it drags cortisol, prolactin, and appetite along for the ride. Ipamorelin gives you clean GHS-R1a activation on somatotrophs without the metabolic noise. Raun et al. (1998, European Journal of Endocrinology) showed cortisol and prolactin staying at baseline even at GH-maximizing Ipamorelin doses.
Pair that with CJC-1295’s extended half-life (6-8 days via DAC-albumin binding) and you get sustained GHRH-R activation underneath clean, pulsatile GHS-R1a stimulation. The blend maintains the natural secretory rhythm while amplifying its magnitude.
Specifications
| Parameter | Detail |
|---|---|
| Components | CJC-1295 (with DAC) + Ipamorelin |
| CJC-1295 MW | 3367.9 g/mol |
| Ipamorelin MW | 711.85 g/mol |
| Receptor Targets | GHRH-R + GHS-R1a (dual-pathway) |
| Purity (HPLC) | ≥99% (each component) |
| Storage | Lyophilized, -20°C recommended |
| Reconstitution | Bacteriostatic water |
Research Applications
The CJC-1295 / Ipamorelin combination is the most widely referenced dual-pathway GH protocol in contemporary peptide research. Common applications include:
- GH-axis dose-response mapping — Characterizing synergistic output curves vs. single-agent controls
- IGF-1 modulation studies — Sustained GH elevation drives hepatic IGF-1 production, relevant for anabolic pathway research
- Body composition research — GH-mediated lipolysis and lean mass effects in animal models
- Bone density protocols — GH/IGF-1 axis effects on osteoblast activity and mineral content
- Sleep architecture studies — GH secretion is tied to slow-wave sleep; dual stimulation amplifies nocturnal pulses
The pre-blended format eliminates a variable that plagues dual-peptide protocols: imprecise co-administration timing. Both compounds reconstitute together, ensuring simultaneous receptor activation.
What Ships to Your Lab
Each vial contains lyophilized CJC-1295 and Ipamorelin in research-grade blend. Both components verified at 99%+ purity via independent HPLC and mass spectrometry. Sealed under nitrogen with desiccant. COA included.
Price: $78.00 per vial
Frequently Asked Questions
Why use a CJC-1295 / Ipamorelin blend instead of separate vials?
The blend guarantees simultaneous receptor activation. Separate vials introduce timing variability that can affect synergistic response magnitude. One reconstitution, one administration, consistent dual-pathway engagement.
What is the synergistic effect of combining CJC-1295 with Ipamorelin?
GHRH-R activation (CJC-1295) primes somatotroph cAMP pathways while GHS-R1a activation (Ipamorelin) triggers calcium-dependent GH vesicle release. Published data shows 2-3x greater GH output compared to either compound alone.
Does this blend cause cortisol or prolactin elevation?
Ipamorelin was specifically chosen for this pairing because of its selectivity. Unlike GHRP-6 or GHRP-2, Ipamorelin does not significantly affect cortisol, prolactin, or appetite at GH-effective doses (Raun et al., 1998).
How long does the blend remain active?
CJC-1295’s DAC modification provides a 6-8 day half-life for the GHRH component. Ipamorelin has a ~2 hour half-life. The blend provides both sustained baseline GHRH-R activation and acute GHS-R1a pulses.
How should the CJC-1295 / Ipamorelin blend be stored?
Store lyophilized at -20°C. After reconstitution with bacteriostatic water, refrigerate at 2-8°C and use within 3-4 weeks.
Is this the same as buying CJC-1295 and Ipamorelin separately?
Same compounds, same purity. The difference is convenience and precision — pre-blended ratios eliminate measuring and mixing steps. Individual CJC-1295 and Ipamorelin vials are also available if your protocol requires independent dosing control.
Where can I buy the CJC-1295 / Ipamorelin blend?
PreWorkout Formula stocks this blend with 99%+ purity and fast shipping. See our complete lineup on the peptides for sale page.
What other peptides pair well with GH-axis research?
IGF-1 LR3 is commonly studied as a downstream effector of GH signaling. BPC-157 and TB-500 are researched in parallel for tissue repair pathways that may intersect with GH/IGF-1 mechanisms.
Related Research Peptides
- CJC-1295 — Individual GHRH analog for single-agent GH research
- Ipamorelin — Individual GHS for selective GH secretagogue studies
- GHRP-6 — Broad-spectrum GH secretagogue for comparative protocols
- IGF-1 LR3 — Long-acting IGF-1 for downstream growth factor research
- BPC-157 — Body protection compound for tissue repair studies
- TB-500 — Thymosin beta-4 fragment for wound healing and migration research
This product is intended for laboratory and research use only. Not for human consumption. All buyers must be qualified researchers or institutions. By purchasing, you agree to use this product solely for legitimate research purposes.
